|
TOLLIP haplotype frequencies in AD patients and controls. |
||||
| Haplotype |
Frequency in AD patients (n = 312) |
95%-CI* |
Frequency in controls (n = 222) |
95%-CI* |
|
|
||||
| C-A-G-T-G-G |
0.437 |
0.396–0.477 |
0.421 |
0.376–0.466 |
| C-A-G-C-G-A |
0.202 |
0.169–0.236 |
0.205 |
0.169–0.245 |
| C-A-G-C-G-G |
0.106 |
0.081–0.133 |
0.138 |
0.104–0.175 |
| C-A-A-C-G-G |
0.091 |
0.069–0.114 |
0.090 |
0.063–0.119 |
| G-G-G-C-G-G |
0.083 |
0.061–0.107 |
0.055 |
0.034–0.076 |
| G-A-G-C-G-G |
0.031 |
0.016–0.046 |
0.023 |
0.009–0.039 |
| C-A-G-C-T-G |
0.026 |
0.014–0.039 |
0.041 |
0.022–0.061 |
|
*95% confidence interval for the haplotype frequency estimate using 10,000 bootstrap samples with replacement (non-parametric bootstrap). | ||||
Schimming et al. BMC Dermatology 2007 7:3 doi:10.1186/1471-5945-7-3 |
||||